Cite
HARVARD Citation
Ramakrishnan, N. et al. (2021). Neurophysiological and clinical effects of the NMDA receptor antagonist lanicemine (BHV‐5500) in PTSD: A randomized, double‐blind, placebo‐controlled trial. Depression and anxiety. 38 (11), pp. 1108-1119. [Online].